USSTOCK.TODAY
Pre-Market
Log in Sign up

GeneDx shares fall 10.2% in Monday after-hours trading following lowered growth guidance

Investing.com +1 · ·by G4L

WGS
WGS GeneDx Holdings Corp
$54.83 -16.57%
View chart & analysis →
  1. 1GeneDx recorded $123.1 million in third-quarter revenue.
  2. 2GeneDx achieved a 5% year-over-year revenue increase in the third quarter.
  3. 3GeneDx lowered its annual growth guidance.

So what's the key point?

GeneDx reported third-quarter revenue of $123.1 million. The stock price fell as the company lowered its annual growth guidance.

Source Investing.com +1 · View original ↗

Related 3-line summaries

GeneDx strengthens profitability with $123.1 million in Q3 revenue The Motley Fool +1 · yesterdayUltra Clean Holdings (UCTT) Q2 net income $8.7 million Associated Press +1 · Aug 4Ionis Pharmaceuticals reports $243 million in third-quarter revenue The Motley Fool +1 · yesterday
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news